Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis
Clicks: 327
ID: 113002
2018
Discontinuation of bDMARDs leads to an increased risk of losing remission or LDA and radiographic progression, while tapering doses of bDMARDs does not increase the risk of relapse (LDA) or radiographic progression, even though there is an increased risk of losing remission.
| Reference Key |
s2018annalsrisk
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Henaux S;Ruyssen-Witrand A;Cantagrel A;Barnetche T;Fautrel B;Filippi N;Lukas C;Raffeiner B;Rossini M;Degboé Y;Constantin A;; |
| Journal | annals of the rheumatic diseases |
| Year | 2018 |
| DOI | DOI not found |
| URL | |
| Keywords |
systematic review
meta-analysis
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
female
male
Withholding Treatment*
risk factors
radiography
antirheumatic agents / therapeutic use*
arthritis
rheumatoid / drug therapy*
disease progression
pmid:29187350
doi:10.1136/annrheumdis-2017-212423
sophie henaux
adeline ruyssen-witrand
arnaud constantin
rheumatoid / diagnostic imaging
biological products / therapeutic use*
maintenance chemotherapy
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.